2026 NPPES data Gynecologic Oncology Physician NPI 1366412116 MD
Verify on CMS →

JOHN LOVECCHIO, MD

Gynecologic Oncology Physician in MANHASSET, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
76
Medicare Part D claims · Gynecologic Oncology Physician avg: 188
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

JOHN LOVECCHIO, MD filed 76 Medicare Part D claims in 2023 as a Gynecologic Oncology Physician in MANHASSET, New York, prescribing 66% generic.

76
Part D claims, 2023
66%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN LOVECCHIO, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

76 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JOHN LOVECCHIO, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN LOVECCHIO, MD?

Quality data not reported

NPI registry status

Active

Issued 01/25/2006

NPI 1366412116

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

76 60% vs specialty avg

2023 prescription claims

Specialty avg: 188

Specialty distribution in New York

How Gynecologic Oncology Physician compares to other specialties among New York providers

New York providers

Gynecologic Oncology Physician share within New York

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Gynecologic Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Gynecologic Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN LOVECCHIO, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 300 COMMUNITY DR, MANHASSET, NY, 11030, with a listed phone of (516) 562-4438. NPI 1366412116 was issued on 01/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOVECCHIO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 76 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $22K in drug spend, split 34% brand-name and 66% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

300 COMMUNITY DR
MANHASSET, NY 11030

Provider Details

NPI 1366412116
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Male
NPI Issued 01/25/2006

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to JOHN LOVECCHIO, MD. To verify JOHN LOVECCHIO, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JOHN LOVECCHIO, MD — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 76 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

76
Total Claims
$22K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
86
Total Day Supply
2,347
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$20K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
0.69

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOHN LOVECCHIO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Famotidine
12
Silodosin
12
Mounjaro
Tirzepatide
11
Repatha Sureclick
Evolocumab
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How JOHN LOVECCHIO, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

JOHN LOVECCHIO, MD's 76 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LOVECCHIO.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN LOVECCHIO, MD's specialty?
JOHN LOVECCHIO, MD specializes in Gynecologic Oncology Physician and practices in MANHASSET, New York. Credentials: MD.
How much does JOHN LOVECCHIO, MD prescribe under Medicare Part D?
In 2023, JOHN LOVECCHIO, MD wrote 76 Medicare Part D claims totaling $22K in drug costs for N/A beneficiaries.
Where is JOHN LOVECCHIO, MD located?
JOHN LOVECCHIO, MD is located at 300 COMMUNITY DR, MANHASSET, NY, 11030. Phone: (516) 562-4438.
What is JOHN LOVECCHIO, MD's NPI number?
JOHN LOVECCHIO, MD's National Provider Identifier (NPI) is 1366412116, issued on 01/25/2006.
Does JOHN LOVECCHIO, MD prescribe more brand-name or generic drugs?
JOHN LOVECCHIO, MD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $20K in brand drug costs.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does JOHN LOVECCHIO, MD prescribe most often?
Based on 2023 Medicare Part D data, JOHN LOVECCHIO, MD's most frequently prescribed drugs include Famotidine, Silodosin, Mounjaro. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN LOVECCHIO, MD accept Medicare?
JOHN LOVECCHIO, MD appears in CMS Medicare data with 76 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN LOVECCHIO, MD's credentials?
JOHN LOVECCHIO, MD's NPI is 1366412116 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology